Professional Documents
Culture Documents
hpb0011 0194
hpb0011 0194
x HPB
REVIEW ARTICLE
Abstract
Background: Globalization and intercontinental migration have not just changed the socioeconomic
status of regions, but have also altered disease dynamics across the globe. Hepatolithiasis, although still
rare, is becoming increasingly evident in the West because of immigration from the Asia-Pacific region,
where the disease prevails in endemic proportions. Such rare but emerging diseases pose a therapeutic
challenge to doctors.
Methods: Here, we briefly introduce the topic of hepatolithiasis and describe features of intrahepatic
stones, the aetiology of hepatolithiasis and the symptoms and sequelae of the condition. We then provide
a comprehensive review of the various management modalities currently in use to treat hepatolithiasis.
Conclusions: In our opinion, and as is evident from the literature, surgery remains the definitive
treatment for hepatolithiasis. However, non-surgical procedures such as cholangiography, although
limited in their therapeutic capabilities, play a vital role in diagnosis and preoperative evaluation.
Keywords
hepatectomy, hepatolithiasis, percutaneous transhepatic cholangiography
Correspondence
Ronald Scott Chamberlain, 94 Old Short Hills Road, Livingston, NJ 07039, USA. Tel: +1 973 322 5195.
Fax: +1 973 322 2471. E-mail: rchamberlain@sbhcs.com
Figure 3 Endoscopic retrograde cholangiopancreatography demonstrating (A) extrabiliary opacification in the left liver, dilated common bile
duct (CBD) and left intrahepatic ducts with multiple lucencies of various sizes, and (B) markedly dilated CBD and left intrahepatic ducts with
ductal branch irregularity indicative of stones or tumours
Figure 4 (A) Preoperative percutaneous transhepatic cholangiography revealing filling defects in significantly dilated common bile duct and
left intrahepatic ducts indicative of stones. (B) Postoperative T-tube cholangiogram revealing no obstruction with free flow of contrast into
the duodenum
Figure 5 (A–C) Preoperative percutaneous transhepatic cholangiography images demonstrating dilated common bile duct and left intrahe-
patic ducts with numerous filling defects compatible with stones or debris
Surgical therapy stricture rate (18.2% vs. 58.3%), longer survival (77.0% vs.
The surgical approach to hepatolithiasis typically involves the 50.0%) and lower disease recurrence rate (16.0% vs. 54.3%) than
removal of the affected segment(s). Hepatectomy removes stones, those who had undergone PTCSL. Cheung and Kwok published
eliminates strictures and the consequent bile stasis which is their series of 174 patients and demonstrated a higher rate of
responsible for stone formation, and eradicates the risk of cho- stone removal by hepatic resection compared with PTCSL
langiocarcinoma; in rare cases it removes a known intraductal (98.0% vs. 70.5%).21 They also noted a lower incidence of cho-
tumour. Indications for hepatectomy in hepatolithiasis are: (i) langitis or biliary sepsis at 5 years follow-up in the hepatectomy
unilobar hepatolithiasis, particularly left-sided; (ii) atrophy, group (13.3% vs. 29.3%). Lee et al. reported 123 patients with
fibrosis and multiple abscesses secondary to cholangitis; (iii) sus- hepatolithiasis and noted a stone clearance rate of 92.7% (114/
picion of concomitant intrahepatic cholangiocarcinoma, and (iv) 123) at initial surgery, which increased to 95.9% (118/123) when
multiple intrahepatic stones with biliary strictures that cannot be combined with postoperative choledochoscopic lithotripsy or
treated percutaneously or endoscopically. Complete removal of ERCP.15 The overall survival rate was 91.7% (111/121) at a
the diseased lobe or segment is crucial to prevent recurrence and median follow-up of 40.3 months. In additional reports com-
progressive liver disease. Otani et al. retrospectively reviewed 54 paring surgical with non-surgical management of hepatolithiasis,
patients treated for hepatolithiasis.20 At 10 years follow-up, Uchiyama et al. demonstrated a similar reduction in disease
patients who had undergone hepatectomy had a lower bile duct recurrence with hepatectomy, and were able to further decrease
the rate of residual stones when hepatectomy was combined with tolithiasis, and conclude that hepatectomy with CBD exploration
intraoperative and/or postoperative cholangioscopy.19,22 In addi- and T-tube drainage has the best longterm outcome.24 Unlike in
tion, Al-Sukhni et al. reported stone clearance in 85.2% (23/27) bilio-intestinal anastomosis, Li et al. recommend subcutaneous
of patients treated with surgery.6 In this series, patients under- tunnel and hepatocholangioplasty with utilization of the gall
went CBD exploration with stone extraction (10/27) or concomi- bladder (STHG) in the treatment of localized hepatolithiasis if
tant liver resection (17/27), with or without construction of a no distal CBD stricture is present and a normal gall bladder
side-to-side choledochojejunostomy and Hutson access loop exists.25 They demonstrated a successful outcome without recur-
(subcutaneous loop of jejunum for interventional access). The rent reflux cholangitis in 95.6% (44/46) of patients treated using
Hutson access loop carried no additional operative morbidity this technique.
and offered an additional approach to residual or recurrent Laparoscopic hepatectomy, although technically difficult, has
stones. Finally, a very recent report published by Nuzzo et al. proved beneficial in hepatolithiasis in rare cases and may offer
revealed good longterm outcomes with partial hepatectomy for postoperative advantages, including a shorter hospital stay, higher
primary hepatolithiasis in 26 patients.8 In this study, 76.9% of serum albumin and lower serum aminotransferases, compared
patients (20/26) had no recurrent episodes of cholangitis, and with open procedures.26 Note that if liver parenchyma is diffusely
another 15.4% (4/26) experienced no more than two cholangitic affected by disease, cirrhosis, portal hypertension and/or hepatic
attacks per year when followed postoperatively over an average failure could develop and liver transplantation may be the only
period of 63 months. The authors reported no postoperative alternative.27
mortality and 20% morbidity secondary to bile leak injuries,
which they admitted could have been avoided with better surgi-
cal technique.8 Catena et al. demonstrated that, in experienced Novel alternatives to surgery
hands, operative morbidity and mortality rates in patients who Alternatives to surgical therapy for hepatolithiasis include endo-
undergo liver resection for hepatolithiasis and hepatic masses are scopic resection of peripheral (away from the hepatic hilum)
similar.1 biliary stenoses to ease evacuation of intrahepatic stones, and
Despite numerous reports of successful surgical outcomes in chemical bile duct embolization (CBDE) using ethanol and
the treatment of hepatolithiasis (Table 3), Vetrone et al. have N-butyl-cyanoacrylate.10,28 These therapies may have a limited
outlined several limitations to surgical therapy.23 Right-sided role in patients at high risk for conventional hepatectomy. Li et al.
stones requiring right hepatectomy were associated with a higher demonstrated successful chemical ‘resection’ of the diseased
morbidity. If a CBD stricture is present or a combination of hepatic lobe and no calculous recurrence with CBDE in two
both extra- and intrahepatolithiasis exists, these authors patients with multiple biliary stones in the inferior branch of the
promote resection of atrophic hepatic segments in bilobar left lateral bile duct complicated with biliary strictures.28 However,
disease with hepaticojejunoanastomosis. By contrast, Li et al. these procedures must be applied in larger series to determine
recommend selective use of hepaticojejunoanastomosis in hepa- their efficacy and longterm outcomes.
Table 3 Major series (ⱖ25 patients in the hepatectomy group) depicting short- and longterm outcomes of hepatectomy, compared in some
cases with outcomes of percutaneous transhepatic cholangioscopic lithotomy or lithotripsy
Series Years Primary Number of Immediate stone Stone recurrence Recurrence rate of
therapy patients extraction rate rate within 5 years cholangitis or biliary
sepsis within 5 years
Uchiyama et al. 200722 1971–2006 Hepatectomy 38 NR 13.9% NR
PTCSL 10 NR 50.0% NR
Otani et al. 199920 1980–1996 Hepatectomy 26 96.2% 5.6% NR
PTCSL 28 96.4% 31.5% NR
Cheung & Kwok 200521 1989–2003 Hepatectomy 52 98.0% NR 13.3%
PTCSL 149 70.5% NR 29.3%
Li et al. 200629 1992–2002 Hepatectomy 161 80.1% NR 15.0%
Nuzzo et al. 20088 1992–2005 Hepatectomy 34 NR NR 15.4%
Cheung et al. 200331 1993–2001 PTCSL 79 76.8% NR 33.3%
25
Li et al. 2005 1994–2003 Hepatectomy 46 NR NR 4.0%
Kim et al. 200632 1994–2004 Hepatectomy 128 94.6% 4.2% 8.4%
Lee et al. 200715 2000–2005 Hepatectomy 123 96.0% NR NR
Figure 6 Management algorithm for hepatolithiasis. US, ultrasound; CT, computed tomography; MRI, magnetic resonance imaging; ESWL,
extracorporeal shock wave lithotripsy; PTC, percutaneous transhepatic cholangiography; PTCSL, percutaneous transhepatic cholangio-
scopic lithotomy or lithotripsy, CBD, common bile duct
Complications of hepatolithiasis treatment stricture removal. Complication rates for hepatectomies have con-
sistently ranged from 30% to 40 ⫾ 5% in several studies, which are
Recurrent biliary sepsis, hepatic fibrosis and cirrhosis are long- comparable with or less than those for non-surgical techniques.
term adverse outcomes usually resulting from inadequate stone or Wound infection is the most common post-hepatectomy compli-
cation and occurs at a rate of 17%.15,29 Bile leakage is another tant cholangiocarcinoma, and if there is high suspicion of an
major complication, for which Li et al. reported an incidence of intrahepatic malignancy, hepatectomy should be performed.
7.4% in a series of 312 patients who underwent hepatectomy for
hepatolithiasis.29 In the majority of these patients (20/23), the bile Acknowledgements
leak was successfully treated with US-guided percutaneous drain- We thank Margaret Eng and Amanda Porter (Saint Barnabas Medical Center
age; one patient required additional endoscopic nasobiliary drain- [SBMC] Library, Livingston, NJ) and Nicole Goode (Department of Radiology,
age (ENBD) and the other two needed systemic administration SBMC) for their assistance.
operation and latest attack of acute cholangitis were independent None declared.
techniques may predispose to subsequent recurrence of cho- iocellular carcinoma: a case report and literature review. Intern Med
46:1191–1196.
langitis and septic complications and the need for repetitive
10. Ono Y, Kaneko K, Ogura Y, Sumida W, Tainaka T, Seo T et al. (2006)
interventions.
Endoscopic resection of intrahepatic septal stenosis: minimally invasive
Biliary strictures and dilatations cause bile stasis, cholangitis
approach to manage hepatolithiasis after choledochal cyst excision.
and stone formation, and if the diseased ducts are not removed Pediatr Surg Int 22:939–941.
the possibility of stone recurrence is very high because the predis- 11. Lei ZM, Ye MX, Fu WG, Chen Y, Fang C, Li J. (2008) Levels of serum
posing factors remain unaltered. Thus, surgical resection remains leptin, cholecystokinin, plasma lipid and lipoprotein differ between
the definitive treatment of hepatolithiasis because its goals include patients with gallstone and/or those with hepatolithiasis. Hepatobiliary
the complete removal of intrahepatic stones and the simultaneous Pancreat Dis Int 7:65–69.
resolution of accompanying strictured bile ducts. Surgery may 12. Perdue DG, Cass OW, Milla C, Dunitz J, Jessurun J, Sharp HL et al.
also reduce the risk of recurrent stone formation, cholangitis and (2007) Hepatolithiasis and cholangiocarcinoma in cystic fibrosis: a case
the development of cholangiocarcinoma. However, PTCSL should series and review of the literature. Dig Dis Sci 52:2638–2642.
13. Okudaira K, Kawaguchi A, Inoue T, Hashiguchi K, Tsuzuki Y, Nagao S
be attempted before other procedures in order to ascertain the
et al. (2006) Endoscopically removed hepatolithiasis associated with cav-
condition of the intrahepatic biliary tract and the location of
ernous transformation of the portal vein and antiphospholipid antibody
stones and biliary strictures or dilatations. A multidisciplinary
syndrome. Dig Dis Sci 51:1952–1955.
algorithmic approach (Fig. 6) integrating interventional radiol- 14. Feng WM, Bao Y, Fei MY, Chen QQ, Yang Q, Dai C. (2003) Platelet
ogy, endoscopy and surgery is a vital component in the complete activation and the protective effect of aprotinin in hepatolithiasis patients.
therapeutic strategy for symptomatic hepatolithiasis. Of note, in Hepatobiliary Pancreat Dis Int 2:602–604.
asymptomatic patients in whom hepatolithiasis is an incidental 15. Lee TY, Chen YL, Chang HC, Chan CP, Kuo SJ. (2007) Outcomes of
finding, the goal should be to exclude the possibility of a concomi- hepatectomy for hepatolithiasis. World J Surg 31:479–482.
16. Reimer P, Schneider G, Schima W. (2004) Hepatobiliary contrast agents 25. Li X, Shi L, Wang Y, Tian FZ. (2005) Middle and longterm clinical out-
for contrast-enhanced MRI of the liver: properties, clinical development comes of patients with regional hepatolithiasis after subcutaneous tunnel
and applications. Eur Radiol 14:559–578. and hepatocholangioplasty with utilization of the gallbladder. Hepatobil-
17. Dahlström N, Persson A, Albiin N, Smedby O, Brismar TB. (2007) Contrast- iary Pancreat Dis Int 4:597–599.
enhanced magnetic resonance cholangiography with Gd-BOPTA and 26. Cai X, Wang Y, Yu H, Liang X, Peng S. (2007) Laparoscopic hepatectomy
Gd-EOB-DTPA in healthy subjects. Acta Radiol 48:362–368. for hepatolithiasis: a feasibility and safety study in 29 patients. Surg
18. Kim YT, Byun JS, Kim J, Jang YH, Lee WJ, Ryu JK et al. (2003) Factors Endosc 21:1074–1078.
predicting concurrent cholangiocarcinomas associated with hepatolithi- 27. Pan GD, Yan LN, Li B, Lu SC, Zeng Y, Wen TF et al. (2005) Liver trans-
asis. Hepatogastroenterology 50:8–12. plantation for patients with hepatolithiasis. Hepatobiliary Pancreat Dis Int
19. Uchiyama K, Onishi H, Tani M, Kinoshita H, Ueno M, Yamaue H. (2002) 4:345–349.
Indication and procedure for treatment of hepatolithiasis. Arch Surg 28. Li FY, Jiang LS, Cheng JQ, Mao H, Li N, Cheng NS et al. (2008)
137:149–153. Treatment of hepatolithiasis by chemical bile duct embolization:
20. Otani K, Shimizu S, Chijiiwa K, Ogawa T, Morisaki T, Sugitani A et al. report on two cases. Surg Laparosc Endosc Percutan Tech 18:86–
(1999) Comparison of treatments for hepatolithiasis: hepatic resection 88.
versus cholangioscopic lithotomy. J Am Coll Surg 189:177–182. 29. Li SQ, Liang LJ, Peng BG, Lai JM, Lu MD, Li DM. (2006) Hepaticojejun-
21. Cheung MT, Kwok PC. (2005) Liver resection for intrahepatic stones. ostomy for hepatolithiasis: a critical appraisal. World J Gastroenterol
Arch Surg 140:993–997. 12:4170–4174.
22. Uchiyama K, Kawai M, Ueno M, Ozawa S, Tani M, Yamaue H. (2007) 30. Lee SE, Jang JY, Lee JM, Kim SW. (2008) Selection of appropriate liver
Reducing residual and recurrent stones by hepatectomy for hepatolithi- resection in left hepatolithiasis based on anatomic and clinical study.
asis. J Gastrointest Surg 11:626–630. World J Surg 32:413–418.
23. Vetrone G, Ercolani G, Grazi GL, Ramacciato G, Ravaioli M, Cescon M 31. Cheung MT, Wai SH, Kwok PC. (2003) Percutaneous transhepatic
et al. (2006) Surgical therapy for hepatolithiasis: a Western experience. J choledochoscopic removal of intrahepatic stones. Br J Surg 90:1409–
Am Coll Surg 202:306–312. 1415.
24. Li SQ, Liang LJ, Peng BG, Lu MD, Lai JM, Li DM. (2007) Bile leakage after 32. Kim BW, Wang HJ, Kim WH, Kim MW. (2006) Favourable outcomes of
hepatectomy for hepatolithiasis: risk factors and management. Surgery hilar duct oriented hepatic resection for high grade Tsunoda type hepa-
141:340–345. tolithiasis. World J Gastroenterol 12:431–436.